Samsung Medison Acquires AI Firm Sonio SAS for $92M

loading Samsung Medison Acquires AI Firm Sonio SAS for $92M

Samsung Medison, a medical equipment subsidiary of Samsung Electronics, has acquired the French AI medtech startup Sonio for approximately $92 million. Sonio, established in 2020, specializes in artificial intelligence applications for diagnostic reporting in obstetrics and gynecology ultrasound. The acquisition aims to bolster Samsung Medison's presence in the AI-powered healthcare solutions sector.

Sonio has gained recognition for its AI-based prenatal screening solution, particularly its key product, Sonio Detect, which received approval from the U.S. Food and Drug Administration in 2023. With this acquisition, Samsung Medison expects to leverage European AI development expertise to enhance its medical imaging and diagnostic capabilities. The deal, which is still pending regulatory approval in France, will see Sonio maintain its headquarters in France as it continues to develop medical reporting technology and diagnostic software for the global market.

Summary

Other news in business